C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/70 (2006.01) A61K 39/00 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01) C07K 14/00 (2006.01) C07K 14/15 (2006.01) C07K 16/00 (2006.01) C12N 7/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2430379
Human endogenous retroviruses of the HML-2 family show up-regulated expression in prostate tumors. This finding can be used in prostate cancer screening, diagnosis and therapy.
L'invention se rapporte à des rétrovirus endogènes humains de la famille des HML-2, dont l'expression est régulée positivement dans des tumeurs de la prostate. Cette invention peut être utilisée pour le dépistage, l'établissement du diagnostic et le traitement du cancer de la prostate.
Escobedo Jaime
Garcia Pablo
Hardy Stephen F.
Williams Lewis T.
Borden Ladner Gervais Llp
Chiron Corporation
Novartis Vaccines And Diagnostics Inc.
LandOfFree
Endogenous retroviruses up-regulated in prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endogenous retroviruses up-regulated in prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endogenous retroviruses up-regulated in prostate cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1490305